About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
Biosimilars
Current news
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2024
16.12.2024
2025 VPAG Rebate Rate
09.12.2024
Medicines UK supply issue dashboard November 2024
05.12.2024
Genericisation of the first wave of GLP-1 weight loss medicines report
26.11.2024
Response to Royal Pharmaceutical Society Report into shortages
20.11.2024
First wave of generic weight loss medicines available in the UK
13.11.2024
Medicines UK names first womens working group chair
31.10.2024
Medicines UK supply issue dashboard October 2024
01.10.2024
Solutions to UK Medicines Shortages
24.09.2024
Medicines UK supply issue dashboard September 2024
12.09.2024
Statement from Medicines UK, which was part of the expert reference group for the Darzi review.
20.08.2024
Medicines UK Supply issue dashboard August 2024
22.07.2024
Medicines UK Supply issue dashboard July 2024
11.06.2024
Medicines UK Supply issue dashboard June 2024
11.06.2024
Paul Burden elected Medicines UK vice-chair
10.05.2024
Medicines UK supply issue dashboard May 2024
03.04.2024
Medicines UK supply issue dashboard April 2024
18.03.2024
Medicines UK Manifesto March 2024
14.02.2024
Medicines UK supply issue dashboard February 2024
24.01.2024
Medicines UK supply issue dashboard January 2024
30.01.2024
Reaction to Labour's Life Sciences Strategy
Highlights
16.12.2024
2025 VPAG Rebate Rate
09.12.2024
Medicines UK supply issue dashboard November 2024
05.12.2024
Genericisation of the first wave of GLP-1 weight loss medicines report
26.11.2024
Response to Royal Pharmaceutical Society Report into shortages
20.11.2024
First wave of generic weight loss medicines available in the UK
13.11.2024
Medicines UK names first womens working group chair
31.10.2024
Medicines UK supply issue dashboard October 2024
01.10.2024
Solutions to UK Medicines Shortages
24.09.2024
Medicines UK supply issue dashboard September 2024
12.09.2024
Statement from Medicines UK, which was part of the expert reference group for the Darzi review.
20.08.2024
Medicines UK supply issue dashboard August 2024
22.07.2024
Medicines UK Supply issue dashboard July 2024
11.06.2024
Medicines UK Supply issue dashboard June 2024